The U.S. Attorney’s Office in Miami is accusing Illinois-based drugmaker Abbott Laboratories of inflating some pharmaceutical prices 1,000 percent to defraud Medicare and Medicaid of $175 million.
According to the complaint, which was unsealed by U.S. District Judge Alan Gold on Wednesday, Abbott inflated prices for some 40 drugs, solutions and injections, including simple sterile water. The drugmaker ratcheted up prices by as much as 10 times, or 1,000 percent.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]